Drop back to the previous dose and attempt escalation again after an additional 2-4 weeks
Around 75% of Americans have heard of GLP-1s, yet perceptions are nuanced
The landmark SUSTAIN-6 trial , published in The New England Journal of Medicine , found that Semaglutide significantly reduced the risk of major adverse cardiovascular events (such as heart attack, stroke, or death from cardiovascular causes) in patients with type 2 diabetes who were at high cardiovascular risk
Do not use if allergic to any of the ingredients
Besides lawsuits filed by people harmed by the drug, Wegovy has also been involved in lawsuits filed by drug maker Novo Nordisk
Total Medicaid drug spending rose to $6 billion in 2025 from $4.8 billion in 2022, according to data provided by the Pennsylvania Department of Human Services